Secondary Metabolites of Medicinal Plants. Bharat SinghЧитать онлайн книгу.
(Afzal et al. 2012). The p-coumaric acid, ferulic acid, syringic acid, caffeic acid, quercetin, and kaempferol were purified by preparative thin layer chromatography from NaHCO3-soluble ether extract of the defatted leaves of K. pinnata (Gaind and Gupta 1973). A mixture of bryotoxins B and C were separated from the flowers of Bryophyllum tubiflorum (Capon et al. 1986).
2.17.2 Culture Conditions
The callus cultures were established with different growth regulators (benzylaminopurine (BAP), naphthaleneacetic acid (NAA) and indole-3-butyric acid (IBA); 2,4-dichlorophenoxyacetic acid (2,4-D) and benzylaminopurine) in B. pinnatum (Gurnani et al. 2014). The cultures were incubated in the darkness at 24 ± 1 °C for 50 days. The percentage of callus induction and the area of explants covered by callus cells were evaluated. The highest percentage of callus induction was 100%, obtained with the combination of 2,4-D and benzyl adenine (BA) (Santos et al. 2014).
References
1 Afzal, M., Gupta, G., Kazmi, I. et al. (2012). Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum. Fitoterapia 83: 853–858.
2 Akihisa, T., Kokke, W.C.M., Tamura, T., and Matsumoto, M. (1991). Sterols of Kalanchoe pinnata: first report of the isolation of both C-24 epimers of 24-alkyl-Δ25-sterols from a higher plant. Lipids 26: 660–665.
3 Akinpelu, D.A. (2000). Anti-microbial activity of Bryophyllum pinnatum leaves. Fitoterapia 71: 193–194.
4 Almedia, A.P. and Costa, S.S. (2006). 1-Octane-3-O-α-l-arabinopyranosyl-(16)-glucopyranoside, a minor constituent from leaves of Kalanchoe pinnata. Braz. J. Pharmacogn. 16: 485–489.
5 Anderson, L.A.P., Steyn, P.S., and van Heerden, F.R. (1984). The characterization of two novel bufadienolides, lanceotoxins A and B from Kalanchoe lanceolata [Forssk]. J. Chem. Soc., Perkin Trans. 1 0: 1573–1575.
6 Anjoo, K. and Kumar, S.A. (2010). Microscopical and preliminary phytochemical studies on aerial part (leaves and stem) of Bryophyllum pinnatum Kurz. Pharmacogn. J. 2: 254–259.
7 Asolkar, L.V., Kakkar, K.K., and Chakre, O.J. (1992). Second Supplement to Glossary of Indian Medicinal Plants with Active Principles, Part I (A–K). New Delhi: CSIR.
8 Bapuji, J.L. and Ratnam, S.V. (2009). Traditional uses of some medicinal plants by tribals of Gangaraju Madugula Mandal of Visakhapatnam District, Andhra Pradesh. Ethnobot. Leafl. 13: 388–398.
9 Belayneh, A. and Bussa, N.F. (2014). Ethnomedicinal plants used to treat human ailments in the prehistoric place of Harla and Dengego valleys, eastern Ethiopia. J. Ethnobiol. Ethnomed. 10: 18.
10 Betschart, C., von Mandach, U., Seifert, B. et al. (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine 20: 351–358.
11 Bussmann, R.W. (2006). Ethnobotany of the Samburu of Mt. Nyiru, South Turkana, Kenya. J. Ethnobiol. Ethnomed. 2: 35.
12 Capon, R.J., MacLeod, J.K., and Oelrichs, P.B. (1986). Bryotoxins B and C, toxic bufadienolide orthoacetates from the flowers of Bryophyllum tubiflorum (Crassulaceae). Aust. J. Chem. 39: 1711–1715.
13 Chopra, R.N., Nayer, S.L., and Chopra, I.C. (1992). Glossary of Indian Medicinal Plants. New Delhi: CSIR.
14 Da Silva, S.A., Costa, S.S., Mendonca, S.C. et al. (1995). Therapeutic effect of oral Kalanchoe Pinnata leaf extract in murine leishmaniasis. Acta Trop. 60: 201–210.
15 Deb, J. and Dash, G.K. (2013). Kalanchoe laciniata (L.) DC: a lesser known Indian medicinal plant. Int. J. Sci. Inventions Today 2: 158–162.
16 El Abdellaoui, S., Destandau, E., Toribio, A. et al. (2010). Bioactive molecules in Kalanchoe pinnata leaves: extraction, purification, and identification. Anal. Bioanal. Chem. 398: 1329–1338.
17 Fürer, K., Eberli, D., Betschart, C. et al. (2015). Inhibition of porcine destrusor contractibility by the flavonoid fraction of Bryophyllum pinnatum – a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine 22: 158–164.
18 Fürer, K., Raith, M., Brenneisen, R. et al. (2013). Two new flavonol glycosides and a metabolic profile of Bryophyllum pinnatum, a phytotherapeutic used in obstetrics and gynaecology. Planta Med. 79: 1565–1571.
19 Gaind, K.N. and Gupta, R.L. (1973). Phenolic components from the leaves of Kalanchoe pinnata. Planta Med. 23: 149–153.
20 Gupta, S. and Banerjee, R. (2011). Radical scavenging potential of phenolics from Bryophyllum pinnatum (LamM.) Oken. Prep. Biochem. Biotechnol. 41: 305–319.
21 Gurnani, C., Kumar, V., Mukhija, S. et al. (2014). Conservation of medicinal plant Bryophyllum pinnatum (Lam.) Kurz by in vitro nodal culture. Int. J. Pharm. Sci. Res. 5: 2406–2411.
22 Huang, H.C., Lin, M.K., and Yang, H.L. (2013). Cardenolides and bufadienolide glycosides from Kalanchoe tubiflora and evaluation of cytotoxicity. Planta Med. 79: 1362–1369.
23 Huang, K.C. (1993). The Pharmacology of Chinese Herbs. Boca Raton, FL: CRC Press.
24 Kamboj, A. and Saluja, A.K. (2009). Bryophyllum pinnatum (Lam.) Kurz.: phytochemical and pharmacological profile: a review. Pharmacogn. Rev. 3: 364–374.
25 Karuppusamy, S. (2007). Medicinal plants used by Paliyan tribes of Sirumalai hills of Southern India. Nat. Prod. Radiance 6: 436–442.
26 Kipkore, W., Wanjohi, B., and Rono, H. (2014). A study of the medicinal plants used by the Marakwet community in Kenya. J. Ethnobiol. Ethnomed. 10: 24.
27 Kirtikar,